TBPH
NASDAQ · Pharmaceuticals
Theravance Biopharma Inc
$16.58
-0.13 (-0.78%)
Analyst Consensus
Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+50.5% upside
Low Target
$16.23
Average Target
$24.95
High Target
$30.59
Current Price
$16.58
Current
$16.58
$16.58
Target
$24.95
$24.95
$16.23
$24.95 avg
$30.59
Scenario Analysis
Bear Case
$16.23
-2.1%
Low target
Base Case
$24.95
+50.5%
Avg target
Bull Case
$30.59
+84.5%
High target
Risk/Reward
40.0x
Highly favorable
Price in Context
52-Week High
$21.03
-21.2% from high
52-Week Low
$10.44
+58.9% from low
Target vs 52W High
$24.95
+18.6% vs high
Peer Consensus — Pharmaceuticals